help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maggi, M.
Right arrow Articles by Serio, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maggi, M.
Right arrow Articles by Serio, M.

Journal of Clinical Endocrinology & Metabolism, Vol 70, 1142-1154, Copyright © 1990 by Endocrine Society


ARTICLES

Human myometrium during pregnancy contains and responds to V1 vasopressin receptors as well as oxytocin receptors

M Maggi, P Del Carlo, G Fantoni, S Giannini, C Torrisi, D Casparis, G Massi and M Serio
Department of Clinical Physiopathology, University of Florence, Italy.

We have recently demonstrated the presence of two classes of neurohypophysial hormone receptors in the vagina, myometrium, and oviduct of rabbit: an oxytocin (OT) site and a V1 arginine vasopressin (AVP) site. We now report binding and in vitro contractility studies on human myometrial specimens obtained at cesarean section from women at the end of pregnancy. The program Ligand was used to analyze self- and cross-displacement curves for labeled OT, AVP or its V1 antagonist d(CH2)5TyrMeAVP, the corresponding unlabeled peptides, and selective analogs. Our results clearly indicate the presence of heterogeneity of binding sites in human uterus. Blocking experiments were performed to evaluate the density of OT and V1 AVP receptors in individual uterine specimens. The contractile response of the same samples to OT, AVP, and analogs was also evaluated. Our results indicate that V1 AVP receptors are present in all of the uterine specimens investigated, with virtually equal density from 32 weeks to term. AVP and the V1-selective agonist [Phe2,Ile3,Orn8]VP stimulate contractility of uterine strips, an effect blocked by nanomolar concentration of the V1 antagonist d(CH2)5TyrMeAVP. Uterine OT receptors increase during late pregnancy, peaking in early labor. A significant correlation between the density of OT receptors and the frequency of uterine contractions (external tocography) was found in pregnant women before surgery. OT stimulated in vitro contractility of uterine strips only when the density of receptors was more than 150 fmol/mg protein. In conclusion, we identified biologically active V1 AVP receptors in human uterus at the end of gestation and confirmed the primary relevance of OT receptors in human parturition.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. P. McCafferty, M. A. Pullen, C. Wu, R. M. Edwards, M. J. Allen, P. M. Woollard, A. D. Borthwick, J. Liddle, D. M. B. Hickey, D. P. Brooks, et al.
Use of a novel and highly selective oxytocin receptor antagonist to characterize uterine contractions in the rat
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R299 - R305.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
L. Vignozzi, G. B. Vannelli, A. Morelli, R. Mancina, M. Marini, P. Ferruzzi, C. Crescioli, M. Luconi, S. Donati, A. D. Fisher, et al.
Identification, characterization and biological activity of oxytocin receptor in the developing human penis
Mol. Hum. Reprod., February 1, 2005; 11(2): 99 - 106.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Cirillo, E. Gillio Tos, M. K. Schwarz, A. Quattropani, A. Scheer, M. Missotten, J. Dorbais, A. Nichols, F. Borrelli, C. Giachetti, et al.
Pharmacology of (2S,4Z)-N-[(2S)-2-Hydroxy-2-phenylethyl]-4-(methoxyimino) -1-[(2'-methyl[1,1'-biphenyl]-4-yl)carbonyl]-2-pyrrolidinecarboxamide, a New Potent and Selective Nonpeptide Antagonist of the Oxytocin Receptor
J. Pharmacol. Exp. Ther., July 1, 2003; 306(1): 253 - 261.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
J.-C. Schellenberg, V. Pliska, and R. A. Lutz
Oxytocin Receptors in Guinea Pig Myometrium Near Term and During Labor
Biol Reprod, February 1, 2000; 62(2): 427 - 431.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
J. A. Copland, Y.-J. Jeng, Z. Strakova, K. L. Ives, M. R. Hellmich, and M. S. Soloff
Demonstration of Functional Oxytocin Receptors in Human Breast Hs578T Cells and Their Up-Regulation through a Protein Kinase C-Dependent Pathway
Endocrinology, May 1, 1999; 140(5): 2258 - 2267.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. McKillen, S. Thornton, and C. W. Taylor
Oxytocin increases the [Ca2+]i sensitivity of human myometrium during the falling phase of phasic contractions
Am J Physiol Endocrinol Metab, February 1, 1999; 276(2): E345 - E351.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1990 by The Endocrine Society